Last update 01 Nov 2024

IGF-1R x CLEC2B

Basic Info

Related Targets
IGF-1RCLEC2B

Related

1
Drugs associated with IGF-1R x CLEC2B
1R-2b
Target
CLEC2B x IGF-1R
Mechanism
CLEC2B modulators [+1]
Active Org.-
Originator Org.
Immunomedics, Inc.Immunomedics, Inc.
Active Indication-
Inactive Indication
Renal Cell Carcinoma
Drug Highest PhasePending
First Approval Ctry. / Loc.-
First Approval Date20 Jan 1800
100 Clinical Results associated with IGF-1R x CLEC2B
Login to view more data
100 Translational Medicine associated with IGF-1R x CLEC2B
Login to view more data
0 Patents (Medical) associated with IGF-1R x CLEC2B
Login to view more data

Analysis

Perform a panoramic analysis of this field.
login
or
view full example data
Perform a panoramic analysis of this field.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free